Company India Globalization Capital, Inc. Nyse
Equities
US45408X3089
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Sciences
87.6
%
| 0 | 90.7 % | 1 | 87.6 % | +122.28% |
Infrastructure
12.4
%
| 0 | 9.3 % | 0 | 12.4 % | +205.41% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
85.3
%
| 0 | 82.9 % | 1 | 85.3 % | +136.17% |
India
12.4
%
| 0 | 17.1 % | 0 | 12.4 % | +66.18% |
Colombia
2.3
%
| - | - | 0 | 2.3 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29/05/29 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09/18/09 |
Chief Tech/Sci/R&D Officer | - | - | |
Jagadeesh Rao
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/17/01 |
Rohit Goel
AUD | Comptroller/Controller/Auditor | 30 | 29/17/29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29/05/29 |
Richard Prins
CHM | Chairman | 67 | 01/07/01 |
Director/Board Member | 79 | 18/22/18 | |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09/18/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,541,532 | 52,940,787 ( 79.56 %) | 0 | 79.56 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |